CDBIO Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Public

  • Employees
  • 1,781

Employees

  • Stock Symbol
  • 688739

Stock Symbol

  • Share Price
  • $3.07
  • (As of Friday Closing)

CDBIO General Information

Description

Liaoning Chengda Biotechnology Co Ltd is engaged in the research and development, production and sales of human vaccines.

Contact Information

Website
www.cdbio.cn
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Corporate Office
  • Number 1 Xinfang Street, Hunnan New District
  • Shenyang, Liaoning
  • China
+86 024
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Stock Exchange
SHG
Vertical(s)
Life Sciences
Corporate Office
  • Number 1 Xinfang Street, Hunnan New District
  • Shenyang, Liaoning
  • China
+86 024

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CDBIO Stock Performance

As of 13-Nov-2026, CDBIO’s stock price is $3.07. Its current market cap is $1.28B with 416M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.07 $3.10 $2.78 - $4.00 $1.28B 416M 1.84M $0.02

CDBIO Financials Summary

As of 30-Sep-2026, CDBIO has a trailing 12-month revenue of $194M.

In Thousands,
USD 		TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 542,699 810,376 739,339 1,121,746
Revenue 194,067 193,329 233,607 247,369
EBITDA 11,720 43,437 72,726 89,228
Net Income 9,426 18,326 47,777 65,856
Total Assets 1,463,648 1,392,972 1,376,911 1,422,193
Total Debt 1,669 1,340 2,074 2,822
Public Fundamental Data provided by Morningstar, Inc. disclaimer

CDBIO Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore CDBIO‘s full profile, request access.

Request a free trial

CDBIO Patents

  • 3

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • Pending

  • Expiring in next 12 mo

CDBIO Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2023060483-A1 Polypeptide-rbd immunoconjugate and use thereof Inactive 13-Oct-2021
US-20130287812-A1 Anti-hpv drug and its application in preparing medicines for treatment of hpv (human papilloma virus) infection Inactive 18-Jan-2011
WO-2012097634-A1 Medicine for treating hpv infection, and its use in preparation of pharmaceuticals for treating hpv infection Inactive 18-Jan-2011 A61K39/205

CDBIO Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

CDBIO ESG

Risk Overview

Risk Rating

Updated March, 31, 2025

39.4 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 14,271

Rank

Percentile

Pharmaceuticals

Industry

of 908

Rank

Percentile

Biotechnology

Subindustry

of 434

Rank

Percentile

To view CDBIO’s complete esg history, request access »

CDBIO FAQs

  • When was CDBIO founded?

    CDBIO was founded in 2002.

  • Where is CDBIO headquartered?

    CDBIO is headquartered in Shenyang, China.

  • What is the size of CDBIO?

    CDBIO has 1,781 total employees.

  • What industry is CDBIO in?

    CDBIO’s primary industry is Drug Discovery.

  • Is CDBIO a private or public company?

    CDBIO is a Public company.

  • What is CDBIO’s stock symbol?

    The ticker symbol for CDBIO is 688739.

  • What is the current stock price of CDBIO?

    As of 13-Nov-2026 the stock price of CDBIO is $3.07.

  • What is the current market cap of CDBIO?

    The current market capitalization of CDBIO is $1.28B.

  • What is CDBIO’s current revenue?

    The trailing twelve month revenue for CDBIO is $194M.

  • What is CDBIO’s annual earnings per share (EPS)?

    CDBIO’s EPS for 12 months was $0.02.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process